Nature’s Sunshine Products (NASDAQ:NATR) Price Target Cut to $36.00 by Analysts at Canaccord Genuity Group

Nature’s Sunshine Products (NASDAQ:NATR) had its price objective reduced by Canaccord Genuity Group from $37.00 to $36.00 in a research report issued to clients and investors on Thursday,Benzinga reports. The firm presently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside of 78.04% from the company’s current price.

Several other research firms have also weighed in on NATR. Weiss Ratings lowered Nature’s Sunshine Products from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. DA Davidson upgraded shares of Nature’s Sunshine Products to a “strong-buy” rating in a research note on Monday, July 6th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $34.50.

Nature’s Sunshine Products Stock Performance

NASDAQ:NATR traded down $0.35 during trading hours on Thursday, hitting $20.22. The stock had a trading volume of 24,480 shares, compared to its average volume of 119,276. The business’s 50 day moving average is $20.89 and its 200-day moving average is $23.64. The company has a market cap of $355.57 million, a price-to-earnings ratio of 18.38 and a beta of 0.87. Nature’s Sunshine Products has a one year low of $12.97 and a one year high of $28.14.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.30 EPS for the quarter, topping the consensus estimate of $0.20 by $0.10. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.The business had revenue of $122.89 million for the quarter, compared to the consensus estimate of $122.15 million.

Insiders Place Their Bets

In other Nature’s Sunshine Products news, EVP Nathan G. Brower sold 12,015 shares of Nature’s Sunshine Products stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $21.84, for a total transaction of $262,407.60. Following the completion of the transaction, the executive vice president directly owned 43,438 shares of the company’s stock, valued at $948,685.92. The trade was a 21.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Daniel C. Norman sold 9,713 shares of Nature’s Sunshine Products stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $20.64, for a total transaction of $200,476.32. Following the sale, the executive vice president directly owned 47,276 shares of the company’s stock, valued at $975,776.64. The trade was a 17.04% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 35,696 shares of company stock worth $742,407. Company insiders own 3.10% of the company’s stock.

Institutional Investors Weigh In On Nature’s Sunshine Products

Several institutional investors and hedge funds have recently added to or reduced their stakes in NATR. First Trust Advisors LP raised its stake in shares of Nature’s Sunshine Products by 1.7% in the fourth quarter. First Trust Advisors LP now owns 44,803 shares of the company’s stock valued at $967,000 after buying an additional 736 shares during the period. Ameriprise Financial Inc. lifted its stake in shares of Nature’s Sunshine Products by 1.4% during the 2nd quarter. Ameriprise Financial Inc. now owns 54,008 shares of the company’s stock valued at $799,000 after buying an additional 753 shares in the last quarter. R Squared Ltd raised its holdings in Nature’s Sunshine Products by 7.7% during the 1st quarter. R Squared Ltd now owns 15,340 shares of the company’s stock valued at $368,000 after acquiring an additional 1,092 shares during the period. State of Alaska Department of Revenue purchased a new stake in Nature’s Sunshine Products in the 4th quarter worth approximately $31,000. Finally, Charles Schwab Investment Management Inc. lifted its position in Nature’s Sunshine Products by 3.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 49,798 shares of the company’s stock worth $1,075,000 after buying an additional 1,513 shares during the last quarter. Hedge funds and other institutional investors own 79.40% of the company’s stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.